Document Detail


Neutropenia associated with rituximab therapy.
MedLine Citation:
PMID:  21102324     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: Several recent studies have reported the occurrence of late-onset neutropenia (LON) following the use of rituximab or rituximab-based therapies. While this phenomenon is typically self-limiting and of no clinical significance, recognizing its existence is important given the expanding use of rituximab in both hematologic and nonhematologic disorders. This review discusses the incidence of LON and explores several hypotheses that have been proposed to explain its occurrence.
RECENT FINDINGS: While the etiology of LON is uncertain and poorly understood, mechanisms that have been suggested include the production of antineutrophil antibodies following rituximab, the expansion of large granular lymphocyte (LGL) populations that may induce neutrophil apoptosis through Fas and Fas-ligand interactions, and aberrant B-cell reconstitution following rituximab leading to immune dyscrasias and the development of neutropenia. We explored an alternative hypothesis that LON following rituximab is caused by perturbations of granulocyte homeostasis, mediated by a complex interaction between B-cell recovery and the chemokine stromal-derived factor-1 (SDF-1).
SUMMARY: While rituximab has been associated with both early and late neutropenia, LON occurring several weeks to several months after the administration of rituximab is a distinct biologic phenomenon that appears to be related to B-cell recovery. Though it occurs frequently, it is a self-limiting process and is rarely associated with significant clinical sequelae.
Authors:
Cliona Grant; Wyndham H Wilson; Kieron Dunleavy
Related Documents :
8543794 - Fas- and activation-induced apoptosis are reduced in human t cells preactivated in the ...
8424124 - Fatty acids, inflammation and immune responses.
10799864 - Engagement of cd4 before tcr triggering regulates both bax- and fas (cd95)-mediated apo...
10467354 - Characterization of apt- cell lines exhibiting cross-resistance to glucocorticoid- and ...
9734474 - Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor i.
24223964 - Plasticity of migrating cd1b(+) and cd1b(-) lymph dendritic cells in the promotion of t...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current opinion in hematology     Volume:  18     ISSN:  1531-7048     ISO Abbreviation:  Curr. Opin. Hematol.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2014-03-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9430802     Medline TA:  Curr Opin Hematol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  49-54     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Small intestine and microbiota.
Next Document:  Neutrophil gelatinase-associated lipocalin as a marker of acute renal disease.